Best Grants for Cancer Nonprofits in Ohio

We administer a number of scholarships, which range from the traditional academic and athletic awards to corporate and special circumstances offerings. Applying for a scholarship is free, so we invite you to spend some time finding opportunities for which you are a good fit.

Ounce of Prevention Scholarship Fund

The purpose of the fund is to provide one or more annual scholarships to graduates of an accredited high school located in Marshall County, Indiana.  

Recipients must be a survivor of cancer, have an immediate family member or friend who experienced cancer, or have demonstrated active participation in community service related to the prevention or cure of cancer.

Alliance for Cancer Gene Therapy

Unlike surgery, chemotherapy and radiation, cell and gene therapies harness the power of your immune system to destroy cancer cells without harming healthy tissue. We fund the research that will make this vision a reality.

Collaborating with partners and funding research fellows, we are transforming cancer treatments today while bringing the world closer to a cure for all cancers tomorrow.

ACGT Investigator Award in Cell and Gene Therapy for SOLID TUMOR CANCERS 

Purpose

Alliance for Cancer Gene Therapy, Inc. (ACGT) funds breakthrough research that is transforming cancer treatment through cell and gene therapy. This ACGT grant award is for those conducting translational cell and gene therapy research specifically in solid tumor cancers.

Research Objectives

Cell and gene therapy for solid tumors poses major challenges driven by antigen heterogeneity, physical exclusion, immunosuppressive microenvironments, genomic instability, and safety limitations. This RFA seeks innovative, translational cell and gene therapy strategies that directly address these barriers.

Proposed approaches should demonstrate the capacity to: (1) overcome antigen escape through multi-targeted designs that broaden patient populations and account for heterogeneity and resistance due to antigen loss; (2) enhance trafficking, infiltration, and persistence within solid tumor sites; (3) resist or reprogram the immunosuppressive tumor microenvironment; and (4) incorporate built-in safety and controllability mechanisms suitable for clinical translation. Successful proposals will integrate these elements to enable durable, precise, and scalable therapeutic impact in solid tumors.

Building on the priorities outlined above, this RFP encourages proposals spanning a broad range of cell and gene therapy (CGT) platforms and rational combinations, including but not limited to:

• Engineered T Cell Approaches
• Innate and Alternative Immune Cell Platforms
• Gene Editing & Synthetic Biology Strategies
• Microenvironment-Modulating Strategies
• Combinatorial Approaches

Proposals that integrate multiple strategies to overcome trafficking, suppression, antigen escape, and safety barriers in a coordinated manner are strongly encouraged. Preference will be given to approaches with clear mechanistic rationale and a credible path toward clinical translation in solid tumors.

The Juan Diego Guadiana Legacy Foundation Scholarship supports students from Las Cruces High School or Doña Ana County, especially those affected by cancer treatment or pursuing health-related fields. This scholarship is open to various backgrounds, including BiPOC and LGBTQIA+ communities. The foundation aims to empower students at different educational stages, ensuring they have the resources necessary to thrive in their academic and professional journeys.

The FY26 Peer Reviewed Cancer Research Program's Idea Award promotes innovative, high-risk cancer research initiatives. It supports groundbreaking concepts that advance cancer knowledge, patient care, and treatment options within the Military Health System. Projects must demonstrate creativity and innovation, avoiding incremental advancements. Notably, the Early Career Investigator Option is available to foster the growth of promising new investigators early in their careers. This award aims to make significant contributions to cancer research for Service Members and Veterans.

The DoW Peer Reviewed Cancer Clinical Trial Award supports the rapid initiation of clinical trials aimed at significantly improving cancer treatment. Projects may range from small pilot studies to large-scale phase III trials, focusing on innovative products, drugs, or devices. This award mandates the inclusion of patient advocates and prohibits animal studies, ensuring that all preclinical work is completed prior to the award start date. Regulatory applications must be submitted if required for the proposed trials.

The FY26 Peer Reviewed Cancer Research Program Impact Award promotes significant research aimed at enhancing clinical cancer care. It requires preliminary data to ensure feasibility and emphasizes projects with a strong potential for immediate impact. This funding supports clinical trials and allows for either a single Principal Investigator or a duo of partnering PIs, ensuring that both can contribute distinct aspects of the research. Applications must be carefully coordinated to avoid withdrawal risks.

The NCI Research Specialist Award (R50) supports clinician scientists involved in NCI-funded clinical trials. This funding opportunity encourages the development of stable research careers by providing salary support and autonomy, allowing clinician scientists to contribute to national clinical trial development and implementation. They play a critical role in sustaining the NCI clinical trials network without serving as principal investigators. This award aims to ensure continuity in cancer research careers.

The NCI Research Specialist Award (R50) supports non-tenure track scientists in cancer research who provide essential contributions within laboratories and core facilities. This award aims to enhance research careers for skilled scientists who do not seek independent investigator funding. Eligible candidates must possess an advanced degree, have at least two years of contribution to NCI-funded research, and dedicate a significant portion of their time to this work. The R50 offers salary support and travel funds to recognize and stabilize these vital roles in cancer research.

Improving Metastatic Prostate Cancer (mPCa) Care Through Innovative Strategies

The National Comprehensive Cancer Network® and Pfizer Global Medical Grants (Pfizer) are collaborating to offer a new grant opportunity seeking proposals for investigator-initiated research to improve mPCa care. Pfizer (hereafter, “Grantor”) is providing $1 Million in funding to support quality improvement studies to advance health care quality, the delivery of quality care, and improve health care provider performance in mPCa care. The Grantor will serve as the funding organization. Grants are available to all investigators from institutions within the United States. 

Aim

To promote the advancement of scientific knowledge, health care provider performance, and/or health care quality improvement focused on improving mPCa care.

A total of $1 Million is available to fund all projects. The intent is to fund 2-5 studies. There is a funding cap of $250,000 per study. Exceptional studies with budgets above this amount will be considered based on scientific merit and must contain a robust justification. All budgets must include line-item information and robust justification.

The Radiation Oncology-Biology Integration Network (ROBIN) Centers, funded by the National Cancer Institute (NCI), aims to enhance national radiation oncology infrastructure through collaborative research. This initiative supports studies on biological responses to radiation treatment in cancer patients, focusing on understanding tumor and tissue changes. By integrating various scientific disciplines and collecting comprehensive data, ROBIN intends to improve cancer care, optimize treatment strategies, and accelerate translational discoveries to enhance patient outcomes.

The Paul Calabresi Career Development Award for Clinical Oncology aims to enhance the training of clinician-scientists in clinical and translational cancer research. This funding opportunity encourages the career growth of researchers but does not permit Scholars to lead independent clinical trials. Instead, it allows participation in clinical trials under the mentorship of an experienced researcher, fostering a collaborative approach to cancer research.

The DoW Rare Cancers Idea Development Award promotes innovative research ideas for rare cancers, encouraging applicants to provide preliminary data and exploratory aims. This funding opportunity, offered by the US DOD: U.S. Army Medical Command, seeks projects with the potential for high-impact findings that can significantly benefit the patient community. It aims to foster new avenues of investigation and support discovery-driven research in the field of rare cancers.

The 2026 Rare Cancers Research Program Resource and Community Development Award aims to enhance rare cancer research through improved resources and datasets. It addresses critical gaps in research resources, communication strategies, and data sharing infrastructures. Key features include engaging patient advocates throughout the research process and ensuring sustainability of community platforms. This funding opportunity emphasizes community building and the dissemination of findings to benefit scientific and patient communities alike.

The National Cancer Institute (NCI) invites applications for innovative technologies aimed at cancer research and clinical care. This funding opportunity supports early-stage projects focused on proof-of-concept studies to assess the feasibility of new methods and tools. Applications should demonstrate significant technical innovation, targeting advancements in cancer biology, early detection, clinical diagnosis, treatment, and epidemiology. Technologies may include novel analysis platforms, imaging technologies, and biospecimen processing innovations, with a focus on cancer applications.

The National Cancer Institute (NCI) invites applications for the R33 grant aimed at advancing emerging technologies in cancer research. This funding opportunity seeks projects that demonstrate significant progress in technology development, focusing on cancer biology, early detection, and clinical diagnosis. Eligible proposals must showcase innovative methodologies that enhance research capabilities, with a strong emphasis on technical validation and broad applicability in cancer applications.

This funding opportunity aims to enhance cancer research among American Indian and Alaska Native populations, focusing on prevention, diagnosis, and treatment in rural areas. The initiative seeks to reduce cancer incidence and mortality rates while ensuring that research findings significantly improve health outcomes for these communities. Eligible organizations are invited to apply, with applications undergoing rigorous peer review to ensure only the most promising projects receive funding.

The National Mesothelioma Virtual Bank (NMVB) aims to enhance biomedical research on malignant mesothelioma by expanding its collection of biospecimens, including tumor tissues and blood samples, alongside demographic and clinical data. Established in 2006, the NMVB serves as a crucial resource for researchers, providing access to a diverse library of samples and data, which can help identify disease markers and develop improved treatment options. This initiative is essential for advancing the understanding and treatment of mesothelioma.

Oncology Nursing Foundation

The mission of the Oncology Nursing Foundation is to support cancer nursing excellence.

Since 1981, the Oncology Nursing Foundation(ONF), through generous contributions from individuals and institutions, has provided more than $33 million in funding to support oncology nursing education, research and leadership development. This funding has translated to career development awards, academic scholarships, research grants, a myriad of specialized educational initiatives, as well as nurse resiliency support. The Foundation’s activities have played a critical role in improving patient care and advancing the oncology nursing profession.

Radiation Oncology Certified Nurse (ROCN™) Exam Scholarship

Recipients receive funding to cover the ONCC ROCN™ Certification exam fee.

Purpose

To support registered oncology nurses who specialize in providing care for adult or pediatric patients with cancer undergoing radiation therapy by providing funding support to cover the ROCN™ Certification exam fee. 

About the Chester County Community Foundation

Our Mission

The Chester County Community Foundation connects people who care with the causes that matter, so their philanthropy makes a difference now and forever.

Stanley’s Dream

Mission Statement

Stanley’s family created Stanley’s Dream to continue their son’s legacy, making his unfulfilled dream to attend college a reality for other students.

Stanley Edwards had a dream: his dream was to attend college. Unlike many 12-year olds, achieving his dream was complicated by the battle he was fighting against brain cancer. A gifted student and promising athlete, Stanley was diagnosed with a brain tumor at age 12. Despite unthinkable obstacles, Stanley persevered toward his dream. Stanley unfortunately passed away in 2002. In a tribute to this courageous young man, his family created Stanley’s Dream to continue his legacy. The number of recipients will vary each year.

The Gilead Research Scholars Program in Oncology supports innovative research from emerging investigators worldwide, focusing on scientific understanding and progress in cancer treatment. Launched in 2008, it offers financial support of up to $180,000 over two years to junior faculty who meet eligibility criteria. The program emphasizes diversity and aims to reduce barriers for underrepresented groups in research, fostering a more inclusive landscape in addressing unmet medical needs.

The Vince Lombardi Cancer Foundation (VLCF) has played a pivotal role in cancer research and education since its inception in 1971, raising over $21 million to support innovative treatments and compassionate care. This private foundation invites applications from recognized healthcare institutions, focusing on funding scientific and medical fellowships. VLCF is dedicated to preventing cancer and improving patient care, ensuring that the spirit of excellence continues in the fight against this disease.

The Western Reserve Health Foundation Grants aim to enhance the health and well-being of Mahoning County residents by addressing diverse health disparities. Grants support innovative projects aligned with the 2023-2025 Community Health Improvement Plan, focusing on mental health, access to care, and community safety. Eligible not-for-profit organizations can apply for funding to implement solutions that directly benefit local populations, with a preference for those connected to the Healthy Community Partnership.

The Trumbull Memorial Health Foundation Grants support innovative health projects in Trumbull County, focusing on mental health, access to care, and community safety. Grants are available to non-profit organizations that directly benefit local residents, with an emphasis on addressing disparities in health outcomes. Eligible applicants include 501(c)3 organizations and government entities, while prioritizing partnerships that align with community health improvement strategies. This rolling application process allows for continuous submissions, ensuring timely funding decisions.

Siemens Healthineers supports charitable donations that align with its focus areas, including diagnostic imaging and oncology. They prioritize well-rated organizations that allocate a significant portion of donations to clinical efforts rather than administrative costs. Events must ensure at least 65% of funds go to the intended cause. Local chapters of national nonprofits should coordinate with their national teams for requests, as Siemens typically does not entertain separate local requests.

Siemens Healthineers USA offers sponsorships to support healthcare initiatives across the U.S. They emphasize funding for healthcare organizations and related events, ensuring that requests comply with eligibility criteria. The company prioritizes diagnostic imaging, laboratory diagnostics, cardiology, and oncology. Applications must be submitted at least 45 days prior to the event, and funding is not available for sole sponsorships or certain excluded initiatives. For more information, visit Siemens Healthineers' official site.

Gilead North America Grants support community-informed programs that enhance healthcare for vulnerable populations. Grants are available for innovative projects addressing HIV, liver diseases, oncology, and inflammatory diseases. Applications are invited from tax-exempt nonprofits based in the U.S. who focus on health equity and community engagement. Gilead prioritizes funding for projects that demonstrate a strong capability to deliver impactful outcomes, helping to eliminate barriers to healthcare and improve access to essential services.

The Scheidel Foundation offers Integrative Cancer Care Grants aimed at enhancing the quality of life for individuals living with cancer. This initiative supports organizations that promote awareness and adoption of integrative practices, targeting both the medical community and patients. The Foundation seeks proposals that foster long-term solutions and innovative programs, focusing on evidence-based information and practices. Grants are available through a selective process, emphasizing transformative impacts in the field.